Patients should speak with their GP or be referred to a Tier 3 or Tier 4 weight management service for a comprehensive assessment
Eli Lilly to seek approval for powerful new obesity drug retatrutide in early 2027 Eli Lilly announced it will file for regulatory approval of its next-generation obesity drug, retatrutide, in the first quarter of 2027 after successful late-stage trials
The rate at which Peptides Weight Loss facilitates weight loss can vary among patients
Patient retention rates reach 85% at six months, with high satisfaction scores for medical care quality
Mental Health and Your Eyes Allergies Solar Eclipses Welcome to Blink Land The effects of gaming and ways to combat eye stress The Screen Time Alliance Gaming and Digital Eye Strain Protecting your vision COVID-19 Eye Health Care Guide for Patients UV Protection Full Picture of Eye Health Eye Exams Corneal Modifications Diet and Nutrition Low Vision and Vision Rehab Resources for teachers back to school GLP-1 Medications and Your Vision GLP-1s (glucagon-like peptide-1 receptor agonists) are a popular prescription medication used to regulate blood sugar in people with type 2 diabetes and, in some cases, to support weight loss and management
The vasomodulatory effects of GLP-1RAs also extend to glaucoma models, although the observed outcomes differ
